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Abstract Maternal smoking during pregnancy increases
the risk of obesity in the offspring. Not much is known
about the associations with other measures of body com-
position. We assessed the associations of maternal smoking
during pregnancy with the development of subcutaneous
fat mass measured as peripheral and central skinfold
thickness measurements in early childhood, in a popula-
tion-based prospective cohort study from early fetal life
onward in the city of Rotterdam, The Netherlands. The
study was performed in 907 mothers and their children at
the ages of 1.5, 6 and 24 months. As compared to non-
smoking mothers, mothers who continued smoking during
pregnancy were more likely to have a younger age and a
lower educational level. Their children had a lower birth
weight, higher risk of small size for gestational age and
were breastfed for a shorter duration (P-values\0.01). We
did not observe differences in peripheral, central and total
subcutaneous fat mass between the offspring of non-
smoking mothers, mothers who smoked in first trimester
only and mothers who continued smoking during preg-
nancy (P [ 0.05). Also, the reported number of cigarettes
smoked by mothers in both first and third trimester of
pregnancy were not associated with peripheral, central and
total subcutaneous fat mass in the offspring at the ages of
1.5, 6 and 24 months. Our findings suggest that fetal
exposure to cigarette smoke during pregnancy does not
influence subcutaneous fat mass in early childhood. Fol-
low-up studies are needed in children at older ages and to
identify associations of maternal smoking during preg-
nancy with other measures of body composition.
Keywords Body composition  Cohort  Maternal
smoking  Obesity  Paediatrics  Skinfold
Abbreviations
SFT Skinfold thickness
ICC Intraclass correlation coefficient
CI Confidence interval
DXA Dual Energy X-ray Absorptiometry
SD Standard deviation
Introduction
Active maternal smoking during pregnancy is a common
and preventable specific adverse environmental exposure
for the fetus [1–3]. Maternal smoking during pregnancy is
associated with fetal growth retardation and increased risks
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of preterm birth and lower birth weight [4–6]. Maternal
smoking during pregnancy also seems to increase the risk
of obesity in the offspring [7, 8]. The mechanisms under-
lying these associations may include developmental adap-
tations leading to changes in body composition and
appetite behaviour [9, 10]. A recent systematic review
suggested that prenatal smoke exposure leads to a higher
body mass index in childhood [11]. However, using body
mass index as outcome does not give information about
body composition [12, 13]. Studies relating maternal
smoking during pregnancy with direct measures of body
composition in the offspring might be important since
adverse body composition and especially unfavourable fat
distribution are important contributors to metabolic syn-
drome outcomes [14]. Thus far, studies on the association
between maternal smoking during pregnancy and measures
of body composition are scarce and showed inconsistent
results [15–17]. Skinfold thickness is a valid and easy to
perform measurement for subcutaneous fat mass assess-
ment in young children in epidemiological studies [12, 13].
For the present study, we hypothesized that active
maternal smoking during pregnancy leads to higher
peripheral, central and total subcutaneous fat mass in
young childhood. We examined in a population-based
prospective cohort study among 907 Dutch mothers and
children followed from early fetal life onwards, the asso-
ciations of exposure to maternal smoking during pregnancy
with peripheral, central and total subcutaneous fat mass at
the ages of 1.5, 6 and 24 months.
Methods
Design
This study was embedded in the Generation R Study, a
population-based prospective cohort study of pregnant
women and their children from fetal life onwards in Rot-
terdam, the Netherlands [18, 19]. Enrolment in the study
was aimed at early pregnancy (gestational age\18 weeks)
but was possible until birth of the child. All children were
born between April 2002 and January 2006, and form a
prenatally enrolled birth-cohort that is currently followed
until young adulthood. Of all eligible children in the study
area, 61% were participating in the study at birth [19].
Additional detailed assessments of fetal and postnatal
growth and development were conducted in third trimester
of pregnancy in a subgroup of 1,232 Dutch mothers and
their children in order to exclude bias due to ethnicity [19].
Dutch ethnicity was defined as having two parents and four
grandparents born in the Netherlands [19, 20]. Pregnant
mothers participating in the Generation R study, who met
this criterion, were approached for the additional
measurements [18, 19]. Of all approached women, 80%
agreed to participate in the subgroup study. In total, 1,039
children participated in at least one of the postnatal
assessments at the ages of 1.5, 6 and 24 months. The study
protocol was approved by the Medical Ethical Committee
of the Erasmus Medical Centre, Rotterdam. Written
informed consent was obtained from all participants or
their parents.
Data collection and measurements
Maternal smoking during pregnancy
Information about maternal smoking was obtained by postal
questionnaires sent in first, second and third trimester of
pregnancy. Response rates for these questionnaires were 91,
80, and 77%, respectively [19]. Active maternal smoking at
enrolment was assessed in the first questionnaire by asking
the mother whether she smoked during her pregnancy. We
grouped mothers into three categories: (1) never smoked;
(2) smoked only until their pregnancy was acknowledged
(first trimester only); and (3) continued to smoke during
pregnancy. This first questionnaire was sent to all mothers,
independently of gestational age at enrolment. In the second
and third questionnaires, the mothers were asked whether
they had smoked during the past 2 months (yes/no).
Mothers who reported in the first questionnaire not to smoke
or to have smoked until their pregnancy was acknowledged,
but reported to have smoked in the second or third ques-
tionnaire were recategorized as ‘‘continued smoking’’.
Among smokers, the number of cigarettes daily smoked was
categorized into the categories: no smoking,\5 cigarettes/
day and[5 cigarettes/day.
Subcutaneous fat mass measurements
and anthropometrics
Subcutaneous fat mass was measured as skinfold thickness
(SFT) at the ages of 1.5, 6 and 24 months on the left side of
the body at four different sites (biceps, triceps, suprailiacal
and subscapular) according to standard procedures by using
a skinfold calliper (Slim Guide, Creative Health Products)
[21]. Four well-trained medical assistants performed all
measurements [22]. The consensus between and among
observers for the medical assistants was analysed using the
intraclass correlation coefficient (ICC) [23, 24]. Intraob-
server ICC was 0.88 and interobserver ICC was 0.76. Total
subcutaneous fat mass was calculated from the sum of
biceps SFT ? triceps SFT ? suprailiacal SFT ? subscap-
ular SFT. Central subcutaneous fat mass was calculated
from the sum of suprailiacal SFT ? subscapular SFT.
Peripheral subcutaneous fat mass was calculated from the
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sum of biceps SFT ? triceps SFT [25, 26]. Body length was
measured in supine position to the nearest millimeter using
a neonatometer and at the age of 24 months, height was
measured by a Harpenden stadiometer (Holtain Limited,
Dyfed, UK) in standing position. Weight was measured in
naked infants to the nearest grams at the ages of 1.5 and
6 months by an electronic infant scale (SECA) and at the
age of 24 months by a mechanical personal scale (SECA).
Covariates
Birth weight, date of birth and sex were obtained from
midwife and hospital registries at birth. Information about
highest attained maternal educational level (low, moderate
and higher), and parity (primipara, multipara) were
obtained at enrolment in the study [27]. Educational level of
the mother was defined according to the classification of
Statistics Netherlands [28]. Maternal height and weight
were assessed at enrolment. Height and weight were mea-
sured while the mother stood without shoes and without
heavy clothing. Body mass index was calculated (kg/m2).
Information on breastfeeding (yes/no) was obtained by
postnatal questionnaires at the ages of 2, 6, and 12 months.
Mothers were asked whether they ever breastfed their child
(yes/no) and at what age they quitted breastfeeding.
Population for analysis
From the total of 1,106 children and their mothers who
gave consent for participating in the postnatal phase, 1,039
children participated in at least one of the postnatal
assessments at the ages of 1.5, 6 and 24 months (Fig. 1).
Children without complete information on maternal
smoking during pregnancy (n = 111) were excluded from
the analyses. Of the remaining 928 live births with com-
plete data on maternal smoking, information about the sum
of skinfold thickness measurements in at least one of the
three visits was available in 907 children. Twins (n = 24)
were not excluded from the analyses, as they did not differ
in the outcome measure from the singletons and no dif-
ferences in results were observed after excluding them.
Missing skinfold measurements were mainly due to crying
behaviour. Percentage of maternal smoking was not dif-
ferent between participating mothers (n = 907) and those
lost to follow-up (n = 325).
Statistical analysis
Differences in baseline characteristics between the maternal
smoking categories were compared with Student’s t test for
continuous variables and Chi-square tests for categorical
variables. Similarly, we tested the differences in peripheral,
central and total subcutaneous fat mass between the
maternal smoking categories at the ages of 1.5, 6 and
24 months. The associations between period of maternal
smoking during pregnancy (no, first trimester only, con-
tinued) and peripheral, central and total subcutaneous fat
mass at the ages of 1.5, 6 and 24 months, were assessed
using multiple linear regression models. The models were
adjusted for potential confounders including child’s age at
visit, sex, maternal education, maternal height and weight,
breastfeeding (yes/no), current height and observer of the
skinfold measurement. Postnatal smoking, birth weight,
parity, maternal alcohol use and maternal age were not
included in the final models since they did not materially
change the effect estimates. Similar regression models were
used for assessing the associations of the reported number
of cigarettes smoked in both first and third trimester of
pregnancy and peripheral, central, and total subcutaneous
fat mass. The associations between period of maternal
smoking during pregnancy and anthropometrics like height,
weight and body mass index at the ages of 1.5, 6 and
24 months, were also assessed using multiple linear
regression models. These models were adjusted for poten-
tial confounders like age at visit, sex, maternal education,
maternal height and weight, and breastfeeding (yes/no).
Tests for trends were performed by treating each cate-
gorized variable as a continuous term and by entering the
variable into the fully adjusted linear regression model. To
handle missing values in covariates (\20% missing), we
performed multiple imputations with a software package
by generating 5 independent datasets for all analyses.
Imputations were based on the relationships between all
covariates included in this study using the Markov Chain
Monte Carlo method. All measures of association are
presented with their 95% CI. Statistical analyses including
the multiple imputations were performed using the Statis-
tical Package of Social Sciences version 17.0 for Windows
(SPSS Inc., Chicago, IL, USA).
Results
Of all mothers included in the analyses, 9.2% (n = 83)
reported smoking in first trimester only and 13.8%
(n = 125) reported continued smoking during pregnancy
(Table 1). Mothers who continued smoking were younger
and lower educated than mothers who never smoked during
pregnancy. Mean birth weights of children from mothers
who never smoked during pregnancy and who continued
smoking were 3,533 grams (SD 545) and 3,267 grams (SD
573), respectively. In children of mothers who continued
smoking, the highest rate for small size for gestational age
(14.4%) and lowest rate for ever breastfeeding (82.5%)
were observed. As compared to mothers who did partici-
pate, those who did not participate were younger
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(P \ 0.01). Furthermore, they had a lower educational
level and were more likely to smoke (P \ 0.01). Their
children were also born more frequently preterm and with a
lower birth weight (P \ 0.05) (data not shown).
Table 2 shows that we observed no differences in the
unadjusted peripheral, central and total subcutaneous fat
mass measurements during childhood between the off-
spring of non-smoking mothers, mothers who smoked in
first trimester and mothers who continued smoking.
Table 3 gives the associations between period of maternal
smoking, and the number of cigarettes smoked per day
among mothers who smoked in first trimester only and
those who continued smoking with peripheral, central
and total subcutaneous fat mass at the ages of 1.5, 6 and
24 months. Smoking in first trimester only and continued
smoking were not significantly associated with subcuta-
neous fat mass at any age. Offspring of mothers who
continued to smoke more than 5 cigarettes per day tended
to have higher peripheral, central and total subcutaneous
fat mass at the age of 24 months (P for trend [0.05).
However, it is likely a chance finding given it didn’t seem
to be an a priori association from the methods and multiple
comparisons. Table 4 shows the associations between
period of maternal smoking, and the number of cigarettes
smoked per day among mothers who smoked in first tri-
mester only and those who continued smoking with height,
weight and body mass index at the ages of 1.5, 6 and
24 months. Children of mothers who continued smoking
tended to have a lower height and weight at all ages
compared to non-smoking mothers. Offspring of mothers
who smoked more than 5 cigarettes per day among those
who smoked in first trimester only and those who contin-
ued smoking, tended to have a lower height and weight
(P for trend\0.10). The association with body mass index
at these ages seems not to be consistent, but tends to a
negative relation with anthropometrics.
Discussion
Main findings
This population-based prospective cohort study showed
that maternal smoking in first trimester only and continued
n = 928 
Maternal smoking information available 
n = 907 
Complete data on maternal smoking and sum 
of skinfold data for at least one visit  
Sum of skinfold data available per age
1.5 months n = 758 
6 months n = 791 
24 months n = 658 
n = 21 
Excluded: no data on sum of skinfold at all ages  
(1.5 months, 6 months and 24 months)   
n = 111 
Excluded: missing data on maternal smoking 
 (based on three questionnaires)  
n = 1106 
Postnatal Focus Cohort and consent for follow- 
up studies
n = 1039 
At least one postnatal visit  
(at 1.5 months, 6 months or 24 months)  
n = 67 
Excluded: no postnatal visit 
 (at 1.5 months, 6 months and 24 months)   
Fig. 1 Flow chart of participants in study
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smoking during pregnancy were not associated with
peripheral, central and total subcutaneous fat mass at the
ages of 1.5, 6 and 24 months.
Strengths and weaknesses
Major strengths of this study are the population-based
prospective design with subjects being studied from early
pregnancy onwards, and information about a large number
of potential confounders available. However, some meth-
odological issues need to be considered. Of the 1,039
children of this study who participated postnatally, infor-
mation about smoking during pregnancy at enrolment was
missing in 11% of all mothers. This non-response would
lead to biased effect estimates if the associations of
maternal smoking during pregnancy with skinfold mea-
surements in early childhood would be different between
those included and not included in the analyses. However,
this seems unlikely because biased estimates in cohort
studies mainly arise from loss to follow-up rather than from
non-response at baseline [29, 30]. The percentage of
mothers who smoked during pregnancy may have been
higher among those not included in the present analyses
than among those who were included. This might have led
to loss of statistical power and some under-estimation of
the estimated effects. Of the postnatal participants, skinfold
thickness measurements were performed in at least 80%.
Missing skinfold measurements were mainly due to
crying behaviour. Information about maternal smoking
during pregnancy was collected by questionnaires, without
Table 1 Characteristics of mothers and their children according to category of maternal smoking during pregnancy
N = 907 No smoking
(n = 699, 77.1%)
Smoked in first trimester
only (n = 83, 9.2%)
Continued smoking
(n = 125, 13.8%)
Maternal characteristics
Age (years) 31.9 (25.3–37.8) 31.2 (22.1–38.4) 30.8 (21.5–38.0)**
Height (cm) 171.3 (6.4) 171.2 (6.6) 169.5 (6.2)**
Weight (kg) 71.7 (13.3) 69.7 (11.3) 71.1 (13.5)
Body mass index (kg/m2) 24.4 (4.3) 23.7 (3.4) 24.7 (4.5)
Highest completed education (%)
Primary school 1.0 4.9 6.4**
Secondary school 30.7 34.9 57.6**
Higher education 68.3 60.2 36.0**
Alcohol consumption in pregnancy (%)
Ever 69.0 85.5** 68.0
Never 31.0 14.5** 31.0
Parity (%)
0 60.9 71.1 57.6
[=1 39.1 28.9 42.4
Birth
Males (%) 51 46 58*
Gestational age (weeks) 40.0 (37.0–42.1) 39.7 (33.9–42.0) 39.8 (35.7–42.1)
Weight (grams) 3,533 (545) 3,458 (659) 3,267 (573)**
Small for gestational age (\5%) 3.1 3.6 14.4**
Low birth weight (\2,500 g) % 3.9 8.4 7.2
Preterm birth (%) 5.2 9.6 6.4
Breastfeeding
Ever (%) 90.6 94.0 82.5**
Duration (months) 5.4 (0.5–12.0) 4.6 (0.5–12.0) 2.5 (0.5–8.5)**
Values are means (SD), percentages or medians (90% range) for variables with skewed distribution
Differences in maternal and child characteristics (compared with the nonsmoking category) were evaluated using Students t test for continuous
variables and chi-squared tests for categorical variables. Gestational age was log-transformed for the t test. Birth weight in SDS was used for the
t test
Small for gestational age is defined as the lowest 5% of gestational age adjusted birth weight
* P \ 0.05 and ** P \ 0.01
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reference to any skinfold measurement. Although assessing
smoking during pregnancy by questionnaire seems to be a
valid method, misclassification may occur [31]. Underre-
porting of maternal smoking across the various smoking
categories may be present and have led to misclassification.
In general, underreporting would lead to underestimation
of differences between children from smoking and non-
smoking mothers. Also, our study group was ethnic
homogeneous and the mothers were highly educated. This
may limit the generalizability of our results [30]. Finally,
we used skinfold thickness as a measure of subcutaneous
fat mass. Skinfold thickness provides a simple, easy, and
quick yet highly informative assessment of regional fatness
in most age groups and can be used in large-scale
epidemiological studies, but has a limitation in differenti-
ating between lean and fat mass of the whole body [12].
Comparison of main findings with other studies
Obesity in both childhood and adulthood lead to different
risk factors for cardiovascular diseases, diabetes type II and
overall mortality [32–43].
Various studies suggest that exposure to maternal
smoking during fetal life leads to overweight and obesity in
childhood. A systematic review by Oken suggested that
prenatal maternal smoking exposure leads to a 50%
increased risk of overweight in childhood at the ages of
3-33 years [11]. Also, a recent meta-analysis using 17
Table 2 Subcutaneous fat mass measurements according to maternal smoking during pregnancy category
N = 907 No smoking
(n = 699, 77.1%)
Smoked in first trimester
only (n = 83, 9.2%)
Continued smoking
(n = 125, 13.8%)
1.5 months (n = 758)
Age (months) 1.60 (1.12–2.47) 1.59 (1.08–2.49) 1.63 (1.03–2.66)
Triceps (mm) 6.6 (4.0–12.0) 6.5 (4.0–12.0) 6.6 (3.5–12.0)
Biceps (mm) 5.5 (3.0–11.0) 5.5 (3.0–10.0) 5.6 (3.0–10.0)
Suprailiacal (mm) 5.8 (3.0–10.0) 5.8 (3.0–10.4) 5.7 (3.0–9.9)
Subscapular (mm) 6.2 (4.0–9.6) 6.3 (4.0–10.0) 6.1 (3.0–9.0)
Peripheral fat mass (mm) 12.2 (7.0–22.2) 12.0 (7.0–22.3) 12.2 (7.0–21.0)
Central fat mass (mm) 12.0 (7.0–19.0) 12.1 (7.8–20.0) 11.8 (7.0–19.0)
Total fat mass (mm) 24.2 (15.0–39.9) 24.1 (15.5–41.4) 24.0 (14.0–40.5)
6 months (n = 791)
Age (months) 6.49 (5.61–7.88) 6.52 (5.70–7.84) 6.48 (5.46–7.91)
Triceps (mm) 7.9 (5.0–13.0) 8.1 (4.7–14.0) 7.8 (5.0–11.4)
Biceps (mm) 6.5 (4.0–11.0) 6.9 (4.0–11.3) 6.6 (4.0–10.0)
Suprailiacal (mm) 6.3 (3.5–10.0) 6.7 (3.5–9.3) 6.1 (3.1–9.8)
Subscapular (mm) 6.3 (4.0–9.0) 6.6 (4.0–9.6) 6.3 (4.0–9.0)
Peripheral fat mass (mm) 14.5 (9.0–22.0) 14.9 (9.0–25.3) 14.4 (9.1–21.0)
Central fat mass (mm) 12.6 (8.0–19.0) 13.3 (8.0–19.0) 12.4 (7.6–18.0)
Total fat mass (mm) 27.1 (19.0–39.0) 28.2 (17.0–43.3) 26.8 (17.1–37.4)
24 months (n = 658)
Age (months) 25.29 (23.79–27.61) 25.45 (23.92–29.16) 25.51 (23.95–28.04)
Triceps (mm) 8.8 (5.0–14.0) 8.7 (4.0–13.3) 9.0 (5.0–13.9)
Biceps (mm) 6.7 (4.0–11.0) 6.6 (3.4–11.7) 6.9 (4.0–11.0)
Suprailiacal (mm) 5.6 (3.0–9.0) 5.8 (3.0–11.3) 5.7 (3.0–9.0)
Subscapular (mm) 6.0 (3.5–9.0) 6.2 (4.0–10.0) 6.3 (4.0–9.8)
Peripheral fat mass (mm) 15.5 (9.0–24.0) 15.3 (9.0–24.8) 15.8 (9.6–24.0)
Central fat mass (mm) 11.6 (7.0–18.0) 12.0 (7.2–18.7) 12.0 (7.0–18.0)
Total fat mass (mm) 27.1 (17.5–40.0) 27.3 (18.0–44.2) 28.0 (18.0–41.1)
Values are medians (90% range). Differences in child characteristics (compared with the non-smoking category) were evaluated using Students
t test for continuous variables
Peripheral subcutaneous fat mass was calculated from the sum of biceps SFT ? triceps SFT. Central subcutaneous fat mass was calculated from
the sum of suprailiacal SFT ? subscapular SFT. Total subcutaneous fat mass was calculated from the sum of biceps SFT ? triceps
SFT ? suprailiacal SFT ? subscapular SFT
300 B. Durmus¸ et al.
123
T
a
b
le
3
A
ss
o
ci
at
io
n
s
o
f
m
at
er
n
al
sm
o
k
in
g
d
u
ri
n
g
p
re
g
n
an
cy
w
it
h
su
b
cu
ta
n
eo
u
s
fa
t
m
ea
su
re
s
in
ch
il
d
re
n
ag
ed
1
.5
,
6
an
d
2
4
m
o
n
th
s
1
.5
m
o
n
th
s
6
m
o
n
th
s
2
4
m
o
n
th
s
P
er
ip
h
er
al
fa
t
(m
m
)
C
en
tr
al
fa
t
(m
m
)
T
o
ta
l
fa
t
(m
m
)
P
er
ip
h
er
al
fa
t
(m
m
)
C
en
tr
al
fa
t
(m
m
)
T
o
ta
l
fa
t
(m
m
)
P
er
ip
h
er
al
fa
t
(m
m
)
C
en
tr
al
fa
t
(m
m
)
T
o
ta
l
fa
t
(m
m
)
M
at
er
n
al
sm
o
k
in
g
N
=
7
8
1
N
=
7
5
9
N
=
7
5
9
N
=
7
9
4
N
=
7
9
2
N
=
8
0
3
N
=
6
7
2
N
=
6
6
0
N
=
6
5
9
N
o
(n
=
6
9
9
)
R
ef
er
en
ce
R
ef
er
en
ce
R
ef
er
en
ce
R
ef
er
en
ce
R
ef
er
en
ce
R
ef
er
en
ce
R
ef
er
en
ce
R
ef
er
en
ce
R
ef
er
en
ce
F
ir
st
tr
im
es
te
r
o
n
ly
(n
=
8
3
)
-
0
.3
0
(-
1
.3
0
,
0
.7
0
)
-
0
.0
2
(-
0
.9
0
,
0
.8
6
)
-
0
.3
2
(-
2
.0
9
,
1
.4
5
)
0
.6
1
(-
0
.3
5
,
1
.5
6
)
0
.6
2
(-
0
.1
9
,
1
.4
3
)
1
.2
2
(-
0
.3
5
,
2
.7
9
)
0
.0
7
(-
1
.0
8
,
1
.2
3
)
0
.4
0
(-
0
.5
2
,1
.3
2
)
0
.4
7
(-
1
.3
6
,
2
.3
0
)
\
5
ci
g
ar
et
te
s/
d
ay
(n
=
5
3
)
-
1
.0
6
(-
2
.2
7
,
0
.1
5
)
-
0
.2
7
(-
1
.3
2
,
0
.7
9
)
-
1
.2
9
(-
3
.4
1
,
0
.8
3
)
0
.2
9
(-
0
.8
9
,
1
.4
6
)
0
.5
0
(-
0
.5
0
,
1
.5
0
)
0
.7
8
(-
1
.1
6
,
2
.7
1
)
0
.6
3
(-
0
.7
6
,
2
.0
1
)
0
.8
5
(-
0
.2
6
,1
.9
6
)
1
.4
8
(-
0
.7
1
,
3
.6
8
)
[
5
ci
g
ar
et
te
s/
d
ay
(n
=
3
0
)
1
.1
0
(-
0
.5
0
,
2
.7
0
)
0
.4
5
(-
0
.9
7
,
1
.8
7
)
1
.5
2
(-
1
.3
4
,
4
.3
8
)
1
.1
7
(-
0
.3
8
,
2
.7
2
)
0
.8
1
(-
0
.5
2
,
2
.1
4
)
1
.9
6
(-
0
.6
2
,
4
.5
3
)
-
0
.9
5
(-
2
.9
0
,
0
.9
9
)
-
0
.4
1
(-
1
.9
7
,1
.1
5
)
-
1
.3
9
(-
4
.4
7
,
1
.6
9
)
P
fo
r
tr
en
d
P
=
0
.8
2
P
=
0
.8
0
P
=
0
.8
2
P
=
0
.1
5
P
=
0
.1
4
P
=
0
.1
0
P
=
0
.7
7
P
=
0
.6
9
P
=
0
.9
9
C
o
n
ti
n
u
ed
(n
=
1
2
5
)
0
.1
3
(-
0
.7
8
,
1
.0
3
)
0
.0
7
(-
0
.7
3
,
0
.8
7
)
0
.2
3
(-
1
.3
8
,
1
.8
4
)
0
.0
2
(-
0
.8
2
,
0
.8
7
)
-
0
.2
8
(-
0
.9
9
,
0
.4
4
)
-
0
.2
6
(-
1
.6
5
,
1
.1
2
)
0
.5
4
(-
0
.5
5
,
1
.6
3
)
0
.4
4
(-
0
.4
4
,1
.3
1
)
1
.0
3
(-
0
.7
2
,
2
.7
8
)
\
5
ci
g
ar
et
te
s/
d
ay
(n
=
5
1
)
-
0
.1
0
(-
1
.4
2
,
1
.2
2
)
-
0
.4
1
(-
1
.5
7
,
0
.7
5
)
-
0
.4
7
(-
2
.8
1
,
1
.8
7
)
-
0
.0
1
(-
1
.2
3
,
1
.2
0
)
-
0
.3
0
(-
1
.3
2
,
0
.7
3
)
-
0
.3
2
(-
2
.3
1
,
1
.6
7
)
-
1
.0
4
(-
2
.6
4
,
0
.5
6
)
-
0
.8
9
(-
2
.2
1
,
0
.4
3
)
-
1
.8
5
(-
4
.4
5
,
0
.7
6
)
[
5
ci
g
ar
et
te
s/
d
ay
(n
=
5
3
)
0
.1
5
(-
1
.1
2
,
1
.4
1
)
0
.0
4
(-
1
.0
6
,
1
.1
4
)
0
.2
2
(-
2
.0
1
,
2
.4
4
)
-
0
.2
2
(-
1
.4
4
,
0
.9
9
)
-
0
.5
4
(-
1
.5
7
,
0
.4
9
)
-
0
.7
7
(-
2
.7
7
,
1
.2
3
)
1
.4
6
(-
0
.0
8
,
3
.0
1
)
1
.2
1
(-
0
.0
4
,
2
.4
6
)
2
.6
7
(0
.2
0
,
5
.1
4
)*
P
fo
r
tr
en
d
P
=
0
.8
8
P
=
0
.8
6
P
=
0
.9
7
P
=
0
.7
5
P
=
0
.2
6
P
=
0
.4
3
P
=
0
.2
4
P
=
0
.2
3
P
=
0
.1
7
V
al
u
es
ar
e
re
g
re
ss
io
n
co
ef
fi
ci
en
ts
(9
5
%
co
n
fi
d
en
ce
in
te
rv
al
)
u
si
n
g
m
u
lt
ip
le
li
n
ea
r
re
g
re
ss
io
n
m
o
d
el
s
M
o
d
el
s
ar
e
ad
ju
st
ed
fo
r
ch
il
d
’s
ag
e
at
v
is
it
,
se
x
,
m
at
er
n
al
ed
u
ca
ti
o
n
,
m
at
er
n
al
h
ei
g
h
t
an
d
w
ei
g
h
t,
b
re
as
tf
ee
d
in
g
ev
er
,
cu
rr
en
t
h
ei
g
h
t
an
d
o
b
se
rv
er
P
er
ip
h
er
al
su
b
cu
ta
n
eo
u
s
fa
t
m
as
s
w
as
ca
lc
u
la
te
d
fr
o
m
th
e
su
m
o
f
b
ic
ep
s
S
F
T
?
tr
ic
ep
s
S
F
T
.
C
en
tr
al
su
b
cu
ta
n
eo
u
s
fa
t
m
as
s
w
as
ca
lc
u
la
te
d
fr
o
m
th
e
su
m
o
f
su
p
ra
il
ia
ca
l
S
F
T
?
su
b
sc
ap
u
la
r
S
F
T
.
T
o
ta
l
su
b
cu
ta
n
eo
u
s
fa
t
m
as
s
w
as
ca
lc
u
la
te
d
fr
o
m
th
e
su
m
o
f
b
ic
ep
s
S
F
T
?
tr
ic
ep
s
S
F
T
?
su
p
ra
il
ia
ca
l
S
F
T
?
su
b
sc
ap
u
la
r
S
F
T
*
P
\
0
.0
5
Maternal smoking during pregnancy and subcutaneous fat mass in early childhood 301
123
T
a
b
le
4
A
ss
o
ci
at
io
n
s
o
f
m
at
er
n
al
sm
o
k
in
g
d
u
ri
n
g
p
re
g
n
an
cy
w
it
h
an
th
ro
p
o
m
et
ri
cs
in
ch
il
d
re
n
ag
ed
1
.5
,
6
an
d
2
4
m
o
n
th
s
1
.5
m
o
n
th
s
6
m
o
n
th
s
2
4
m
o
n
th
s
H
ei
g
h
t
(c
m
)
W
ei
g
h
t
(g
)
B
o
d
y
M
as
s
In
d
ex
(k
g
/m
2
)
H
ei
g
h
t
(c
m
)
W
ei
g
h
t
(g
)
B
o
d
y
M
as
s
In
d
ex
(k
g
/m
2
)
H
ei
g
h
t
(c
m
)
W
ei
g
h
t
(g
)
B
o
d
y
M
as
s
In
d
ex
(k
g
/m
2
)
M
at
er
n
al
sm
o
k
in
g
N
=
7
6
5
N
=
7
6
7
N
=
7
6
5
N
=
7
7
4
N
=
7
7
6
N
=
7
7
4
N
=
6
7
1
N
=
6
9
2
N
=
6
7
1
N
o
(n
=
6
9
9
)
R
ef
er
en
ce
R
ef
er
en
ce
R
ef
er
en
ce
R
ef
er
en
ce
R
ef
er
en
ce
R
ef
er
en
ce
R
ef
er
en
ce
R
ef
er
en
ce
R
ef
er
en
ce
F
ir
st
tr
im
es
te
r
o
n
ly
(n
=
8
3
)
-
0
.5
1
(-
1
.0
6
,
0
.0
3
)
-
5
(-
1
5
2
,
1
4
2
)
0
.2
2
(-
0
.1
3
,
0
.5
6
)
-
0
.2
4
(-
0
.8
0
,
0
.3
3
)
1
0
7
(-
8
7
,
3
0
0
)
0
.3
5
(0
.0
3
,
0
.6
7
)*
0
.1
4
(-
0
.6
0
,
0
.8
8
)
1
2
(-
3
1
0
,
3
3
4
)
-
0
.1
1
(-
0
.4
4
,
0
.2
1
)
\
5
ci
g
ar
et
te
s/
d
ay
(n
=
5
3
)
-
0
.6
2
(-
1
.1
1
,
-
0
.1
3
)*
-
1
0
1
(-
2
3
5
,
3
2
)
0
.0
1
(-
0
.3
0
,
0
.3
2
)
-
0
.2
0
(-
0
.7
0
,
0
.3
0
)
1
8
(-
1
5
8
,
1
9
4
)
0
.1
4
(-
0
.1
6
,
0
.4
3
)
-
0
.1
9
(-
0
.8
8
,
0
.5
0
)
-
4
2
(-
3
4
3
,
2
5
8
)
-
0
.0
5
(-
0
.3
5
,
0
.2
5
)
[
5
ci
g
ar
et
te
s/
d
ay
(n
=
3
0
)
-
0
.9
0
(-
1
.4
6
,
-
0
.3
4
)*
*
-
2
0
0
(-
3
5
3
,
-
4
6
)*
-
0
.1
9
(-
0
.5
5
,
0
.1
7
)
-
0
.6
3
(-
1
.1
8
,
-
0
.0
7
)*
-
5
2
(-
2
4
6
,
1
4
2
)
-
0
.1
9
(-
0
.1
3
,
0
.5
2
)
-
0
.4
2
(-
1
.1
9
,
0
.3
4
)
-
2
0
8
(-
5
4
4
,
1
2
7
)
-
0
.1
5
(-
0
.4
9
,
0
.1
9
)
P
fo
r
tr
en
d
P
\
0
.0
1
P
\
0
.0
1
P
=
0
.3
8
P
=
0
.0
3
P
=
0
.7
1
P
=
0
.1
7
P
=
0
.2
5
P
=
0
.2
4
P
=
0
.3
8
C
o
n
ti
n
u
ed
(n
=
1
2
5
)
-
0
.9
6
(-
1
.4
6
,
-
0
.4
7
)*
*
-
2
6
8
(-
4
0
2
,
-
1
3
4
)*
*
-
0
.3
3
(-
0
.6
4
,
-
0
.0
1
)*
-
0
.4
5
(-
0
.9
4
,
0
.0
5
)
-
1
0
3
(-
2
7
4
,
6
8
)
-
0
.0
1
(-
0
.2
9
,
0
.2
8
)
-
0
.6
9
(-
1
.3
8
,
0
)
-
2
6
3
(-
5
6
7
,4
2
)
-
0
.1
1
(-
0
.4
2
,
0
.1
9
)
\
5
ci
g
ar
et
te
s/
d
ay
(n
=
5
1
)
-
1
.0
2
(-
1
.7
5
,
-
0
.3
0
)*
*
-
2
6
4
(-
4
6
1
,
-
6
7
)*
*
-
0
.2
7
(-
0
.7
3
,
0
.1
9
)
-
0
.4
1
(-
1
.1
2
,
0
.3
1
)
-
1
4
4
(-
3
9
0
,
1
0
2
)
-
0
.1
0
(-
0
.5
1
,
0
.3
0
)
-
0
.8
8
(-
1
.9
1
,
0
.1
6
)
-
5
2
4
(-
9
7
4
,
-
7
3
)*
-
0
.4
4
(-
0
.8
9
,
0
.0
1
)
[
5
ci
g
ar
et
te
s/
d
ay
(n
=
5
3
)
-
1
.1
4
(-
1
.8
3
,
-
0
.4
5
)*
*
-
3
6
3
(-
5
5
0
,
-
1
7
5
)*
*
-
0
.5
3
(-
0
.9
7
,
-
0
.0
9
)*
-
0
.5
4
(-
1
.2
4
,
0
.1
7
)
-
1
8
9
(-
4
3
1
,
5
3
)
-
0
.1
4
(-
0
.5
4
,
0
.2
7
)
-
0
.8
0
(-
1
.7
5
,
0
.1
6
)
-
2
2
9
(-
6
5
3
,
1
9
4
)
0
.0
2
(-
0
.4
0
,
0
.4
5
)
P
fo
r
tr
en
d
P
\
0
.0
1
P
\
0
.0
1
P
=
0
.0
1
P
=
0
.0
8
P
=
0
.0
7
P
=
0
.4
3
P
=
0
.0
4
P
=
0
.0
7
P
=
0
.5
4
V
al
u
es
ar
e
re
g
re
ss
io
n
co
ef
fi
ci
en
ts
(9
5
%
co
n
fi
d
en
ce
in
te
rv
al
)
u
si
n
g
m
u
lt
ip
le
li
n
ea
r
re
g
re
ss
io
n
m
o
d
el
s
M
o
d
el
s
ar
e
ad
ju
st
ed
fo
r
ch
il
d
’s
ag
e
at
v
is
it
,
se
x
,
m
at
er
n
al
ed
u
ca
ti
o
n
,
m
at
er
n
al
h
ei
g
h
t
an
d
w
ei
g
h
t,
b
re
as
tf
ee
d
in
g
ev
er
*
P
\
0
.0
5
an
d
*
*
P
\
0
.0
1
302 B. Durmus¸ et al.
123
studies showed that maternal smoking during pregnancy
was consistently associated with obesity in children with a
mean age of 9 years [8]. It has been suggested that there is
a dose-response association between the number of smoked
cigarettes and the risk of childhood obesity [44]. These
studies used body mass index as measure for childhood
obesity. Using body mass index does not provide infor-
mation about fat distribution [12]. A limited number of
studies focused on the associations of maternal smoking
during pregnancy with direct measures of body composi-
tion instead of body mass index. A study in Southampton
showed in 448 neonates that maternal smoking in late
pregnancy was weakly associated with a lower fat mass
percentage and greater lean mass percentage [45]. Another
study in Sweden and Norway observed in 315 children
aged 5 years that maternal smoking was associated with an
increased risk of skinfold thickness higher than the 85th
percentile, however the associations attenuated after
adjustment for confounders like total energy intake of the
parents [17]. In contrast, a study in Boston, among 746
children at the age of 3 years, showed no association of
maternal smoking during pregnancy with central adiposity,
measured by the subscapular and triceps ratio, which has
been found to be a valid proxy for intra-abdominal adipose
tissue among children [15].
A study in Bristol, the United Kingdom found in 5,689
children with mean age of 10 years that maternal smoking
at any time during pregnancy is associated with higher
offspring total fat mass measured with Dual X-ray
Absorptiometry (DXA). Maternal smoking was also
associated with higher lean mass, but to a lesser extent
[16]. In our study, we used skinfold thickness as measure
of subcutaneous fat mass at the ages of 1.5, 6 and
24 months. We did not find significant associations
between maternal smoking during pregnancy and periph-
eral, central and total subcutaneous fat mass in early
childhood. We also did not observe associations between
the number of cigarettes smoked during pregnancy and
peripheral, central and total subcutaneous fat mass in the
offspring. Most previous studies assessed the associations
between maternal smoking and adiposity at older age. The
lack of association in this study might be due to the
younger age groups, or use less advanced measuring
techniques. This might also be the explanation for the
inconsistent associations between maternal smoking dur-
ing pregnancy and body mass index. In the future, genome
wide association studies might identify new genetic loci
related to skinfold thickness [46].
Studies examining the influence of prenatal smoke
exposure in different periods of pregnancy might identify
critical time periods, which are important from both a
developmental and preventive perspective. We showed that
both maternal first trimester smoking and continued
smoking were not associated with peripheral, central and
total subcutaneous fat mass until the age of 2 years.
Conclusion
Our findings suggest that intrauterine exposure to maternal
cigarette smoke in different periods during pregnancy does
not influence peripheral, central and total subcutaneous fat
mass development in early childhood. Further studies are
needed in children at older ages and to identify associations
of maternal smoking during pregnancy with other measures
of body composition like DXA and Magnetic Resonance
Imaging.
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